- Poster presentation
- Published:
The correlation between creatine kinase and myoglobin in critical ill patients with rhabdomyolysis
Critical Care volume 8, Article number: P155 (2004)
Purpose
Following rhabdomyolysis there is a risk of acute renal failure (ARF). The nephrotoxic molecule is myoglobin (M). In clinical practice, creatine kinase (CK) is, however, measured to estimate the risk of ARF. It is often stated that the elimination of M is unpredictable [1]. The aim of the present study was therefore to investigate the correlation between CK and the effector molecule M.
Methods and materials
From 1 January 2003 until 30 June 2003 we prospectively measured CK and M in all patients in the ICU suspected of rhabdomyolysis. To investigate the observed trends further, we retrospectively studied all patients submitted to our ICU within the last 4.5 years with a plasma M > 5000 μg/l. Forty-two patients were included.
Results
Plasma M peaked on average 0.6 ± 0.4 days before CK. In the 76% of the patients M and CK increased in parallel and both decreased exponentially T 1/2 (M) 22 ± 10 hours and T 1/2 (CK) 26 ± 7 hours (Fig. 1.) In 17% of the patients an isolated increase in M was observed. In the majority of these patients abdominal complications was found. In 7% of the patients an isolated increase in CK was observed, typically in relation to mobilisation of the patients. ARF was treated with continuous venovenous haemofiltration.

Figure 1
Discussion
In the majority of patients with rhabdomyolysis, M and CK increase and decrease in parallel. Medium-sized molecules such as M are transported directly from the muscle to the blood, while large molecules such as CK are transported with the lymphatic system. Therefore an isolated increase in plasma CK might be observed following mobilisation. An isolated increase in plasma M ought to raise suspicion of abdominal complications.
Conclusion
In patients with rhabdomyolysis, measurement of the nephrotoxic molecule M can be used to predict the risk of ARF.
References
de Meijer, et al.: Serum CK as predictor of clinical course in rhadomyolysis: a 5 year extensive case survey. Intensive Care Med 2003, 29: 1121-1125. 10.1007/s00134-003-1800-5
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mikkelsen, T., Toft, P. The correlation between creatine kinase and myoglobin in critical ill patients with rhabdomyolysis. Crit Care 8 (Suppl 1), P155 (2004). https://doi.org/10.1186/cc2622
Published:
DOI: https://doi.org/10.1186/cc2622